A Randomized, Controlled Trial of Magnesium Sulfate for the Prevention of Cerebral Palsy

Abstract

Fetal exposure to magnesium sulfate before anticipated early preterm delivery did not reduce the combined risk of moderate or severe cerebral palsy or death, although the rate of cerebral palsy was reduced among survivors. (ClinicalTrials.gov number, NCT00014989.)